Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

E. Frei, C. Visco, Z. Y. Xu-Monette, S. Dirnhofer, K. Dybkræ, A. Orazi, G. Bhagat, E. D. Hsi, J. H. Van Krieken, M. Ponzoni, R. S. Go, M. A. Piris, M. B. Møller, Ken H. Young, Alexander Tzankov

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences